ezra tirzepatide Users of Zepbound or Mounjaro Had Lower Blood Pressure in Study Ezra | personalized care should

doi: 159

doi: 10.1016/bs.vh.2021.12.005 61 LarsenPJTang-ChristensenMHolstJJOrskovC

A large number of clinical studies have shown that this loss of appetite caused by treatment with semaglutide or tirzepatide is associated with a significant decrease in body weight in people who suffer from obesity

While semaglutide focuses on one pathway, tirzepatide is a dual-action agonist , meaning it activates two different hormone receptors, not just one

Here are some key points from the article by Beth Ann Mayer

These effects are usually temporary, often appear during dose increases, and tend to improve as the body adjusts